New Biotech Firm Launches with $30 Million too Explore Heritable Genome editing
May 2025 – A new public-benefit corporation, Preventive Medicine PBC, has launched with $30 million in funding to research teh possibility of heritable genome editing - altering genes in a way that would be passed down to future generations. The company, incorporated in Delaware, aims to determine weather such editing can be performed safely, stating that even a conclusion of unsafety would be a valuable contribution to the scientific community.
Preventive Medicine PBC was founded by Janus Harrington, a cofounder and current board member of gene-editing company Mammoth Biosciences, which focuses on therapies for adults. Harrington stated the funding comes from “private funders who share our commitment to pursuing this research responsibly,” but declined to name them beyond identifying SciFounders, a venture firm he co-runs.
SciFounders is led by Matt Krisiloff, CEO of Conception, a biotech company working to create human eggs from stem cells. Krisiloff is also listed as a member of Preventive’s founding team.
So far, Preventive has secured only one public endorsement: Paula Amato, a fertility doctor at Oregon Health Sciences University, who has agreed to serve as an advisor. amato has been involved in US-based research on embryo editing as 2017 and has previously advocated for the technology as a potential way to improve IVF success rates by correcting genetic abnormalities in embryos.
Interest in gene-edited babies is growing among investors, especially within the cryptocurrency sector.Brian Armstrong, founder and CEO of Coinbase, has hosted private dinners to discuss the technology, including one attended by Harrington. Armstrong has publicly stated he believes ”the time is right” for investment in this area.
